{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:58:45Z","timestamp":1791305925307,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.thromres.2008.04.022","type":"journal-article","created":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T05:16:28Z","timestamp":1222838188000},"page":"429-435","source":"Crossref","is-referenced-by-count":64,"title":["Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: A cross-over study"],"prefix":"10.1016","volume":"123","author":[{"given":"K.","family":"Fleischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.R.","family":"Rosendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rosing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tchaikovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.","family":"Helmerhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2008.04.022_bib1","first-page":"CD003552","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception","volume":"1","author":"Gallo","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.thromres.2008.04.022_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2008.04.022_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Updat"},{"key":"10.1016\/j.thromres.2008.04.022_bib4","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study","volume":"346","author":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2008.04.022_bib5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2008.04.022_bib6","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2008.04.022_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2008.04.022_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.thromres.2008.04.022_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinylestradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2008.04.022_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2007.03.003","article-title":"Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of contraceptives containing 35\u00a0\u00b5g ethinyl estradiol","volume":"76","author":"Jick","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2008.04.022_bib11","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2008.04.022_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.04.022_bib13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2003.04443.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women","volume":"122","author":"Tans","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2008.04.022_bib14","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.thromres.2008.04.022_bib15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9378(03)00950-5","article-title":"Sex hormone\u2013binding globulin\u2013a surrogate marker for the prothrombotic effects of combined oral contraceptives","volume":"190","author":"van Rooijen","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2008.04.022_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/humrep\/deh612","article-title":"Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens","volume":"20","author":"van Vliet","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.thromres.2008.04.022_bib17","unstructured":"World Health Organization (1996, 2004). Improving Access to Quality Care in Family Planning. Medical Eligibility Criteria for Contraceptive Use. World Health Organization, Geneva. (www.who.int\/reproductive-health\/publications\/mec\/)."},{"key":"10.1016\/j.thromres.2008.04.022_bib18","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/sim.1783","article-title":"Sample sizes for clinical trials with Normal data","volume":"23","author":"Julious","year":"2004","journal-title":"Statist Med"},{"key":"10.1016\/j.thromres.2008.04.022_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2008.04.022_bib20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2008.04.022_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinylestradiol and a combined oral contraceptive containing levonorgestrel on haemostasis variables","volume":"195","author":"Rad","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2008.04.022_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0010-7824(02)00473-0","article-title":"Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties","volume":"67","author":"Hammond","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2008.04.022_bib23","unstructured":"EMEA. Committee for Proprietary Medicinal Products (CPMP) public assessment report on combined oral contraceptives and venous thromboembolism. (http:\/\/www.emea.eu.int\/pdfs\/human\/regaffair\/0220101en.pdf)."},{"key":"10.1016\/j.thromres.2008.04.022_bib24","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of thromboembolism with cyproterone or levonorgestrel contraceptives","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938480800193X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938480800193X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T06:23:18Z","timestamp":1557814998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938480800193X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S004938480800193X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2008.04.022","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}